, Marine n-3 fatty acid intake, glutathione S -transferase polymorphisms and breast cancer risk in post-menopausal Chinese women in Singapore , Carcinogenesis , vol
BMI 30.0 to 34.9 (class I obesity)
Combining lower-dose folinic acid (200-800 mcg) with root cause treatment often outperforms other treatmentswith fewer side effects
10 Intracellular GSH concentrations differ among tissues, typically ranging from 1 to 10 mM, with the highest levels observed in the liver
Quantity limits
The decision to combine these agents must be individualized based on patient-specific factors, including medical history, current medications, cardiovascular health, and response to previous weight management interventions